Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

MTRC released a seminar on reimbursement system for medical technologies in Luxembourg

Luxembourg is a small country in a central Europe.

From the market access perspective, it has a relatively simple structure with hospitals being funding using a global budget principle, but physicians (in both hospital and out-patient settings) being reimbursed using a fee for service model. The inclusion of novel procedures into the Nomenclature of medical services represents the key challenge of market access for medical technologies in Luxembourg.

We offer a seminar on critical elements of the hospital and out-patient reimbursement system for medical devices in Luxembourg that can guide your decision-making about the introduction of novel technologies into this market.

The seminar discusses key stakeholders, money flow, reimbursement in hospital and ambulatory settings, Nomenclature of medical services, specifics of reimbursement processes and the role of HTA.

Learn more and request a quote here: